Direct head-to-head data against tirzepatide showed CagriSema underperforming the highest tirzepatide dose at 84 weeks meaning monotherapy claims of comparable efficacy are not supported by current Phase 3 evidence
Type 2 diabetes glucose control, usually alongside metformin
The gentle ramp from 0.25 mg up to 2.4 mg mirrors the phase 2 dose-finding schedule that achieved meaningful weight loss while keeping nausea and other gastrointestinal effects manageable [1] [4]
BPC-157 Alone $250/mo 1 per session Targeted gut healing or tendon repair where TB-500 isn't needed
To lessen the impact of future shots on your routine, try getting the injection in your nondominant arm
De Falco M, Lucariello A, Iaquinto S, Esposito V, Guerra G, De Luca A (2015) Molecular mechanisms of Helicobacter pylori pathogenesis